Sökning: WFRF:(Matic Ivan) > ADP-ribosyltransfer...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08462naa a2200937 4500 | |
001 | oai:DiVA.org:uu-497477 | |
003 | SwePub | |
008 | 230301s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4974772 URI |
024 | 7 | a https://doi.org/10.1111/febs.161422 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Lüscher, Bernhardu Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.4 aut |
245 | 1 0 | a ADP-ribosyltransferases, an update on function and nomenclature |
264 | c 2021-09-13 | |
264 | 1 | b John Wiley & Sons,c 2022 |
338 | a electronic2 rdacarrier | |
520 | a ADP-ribosylation, a modification of proteins, nucleic acids, and metabolites, confers broad functions, including roles in stress responses elicited, for example, by DNA damage and viral infection and is involved in intra- and extracellular signaling, chromatin and transcriptional regulation, protein biosynthesis, and cell death. ADP-ribosylation is catalyzed by ADP-ribosyltransferases (ARTs), which transfer ADP-ribose from NAD+ onto substrates. The modification, which occurs as mono- or poly-ADP-ribosylation, is reversible due to the action of different ADP-ribosylhydrolases. Importantly, inhibitors of ARTs are approved or are being developed for clinical use. Moreover, ADP-ribosylhydrolases are being assessed as therapeutic targets, foremost as antiviral drugs and for oncological indications. Due to the development of novel reagents and major technological advances that allow the study of ADP-ribosylation in unprecedented detail, an increasing number of cellular processes and pathways are being identified that are regulated by ADP-ribosylation. In addition, characterization of biochemical and structural aspects of the ARTs and their catalytic activities have expanded our understanding of this protein family. This increased knowledge requires that a common nomenclature be used to describe the relevant enzymes. Therefore, in this viewpoint, we propose an updated and broadly supported nomenclature for mammalian ARTs that will facilitate future discussions when addressing the biochemistry and biology of ADP-ribosylation. This is combined with a brief description of the main functions of mammalian ARTs to illustrate the increasing diversity of mono- and poly-ADP-ribose mediated cellular processes. | |
650 | 7 | a NATURVETENSKAPx Biologix Biokemi och molekylärbiologi0 (SwePub)106022 hsv//swe |
650 | 7 | a NATURAL SCIENCESx Biological Sciencesx Biochemistry and Molecular Biology0 (SwePub)106022 hsv//eng |
653 | a ADP-ribosylation | |
653 | a MARylation | |
653 | a PARP | |
653 | a PARylation | |
653 | a posttranslational modification | |
700 | 1 | a Ahel, Ivanu Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.4 aut |
700 | 1 | a Altmeyer, Matthiasu Univ Zurich, Dept Mol Mech Dis, Zurich, Switzerland.4 aut |
700 | 1 | a Ashworth, Alanu UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA.4 aut |
700 | 1 | a Bai, Peteru Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary.4 aut |
700 | 1 | a Chang, Paulu ARase Therapeut, Cambridge, MA USA.4 aut |
700 | 1 | a Cohen, Michaelu Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA.4 aut |
700 | 1 | a Corda, Danielau CNR, Dept Biomed Sci, Rome, Italy.4 aut |
700 | 1 | a Dantzer, Francoiseu CNRS, BSC UMR7242, Illkirch Graffenstaden, France.4 aut |
700 | 1 | a Daugherty, Matthew D.u Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.4 aut |
700 | 1 | a Dawson, Ted M.u Johns Hopkins Univ, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Sch Med, Baltimore, MD USA.4 aut |
700 | 1 | a Dawson, Valina L.u Johns Hopkins Univ, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Sch Med, Baltimore, MD USA.4 aut |
700 | 1 | a Deindl, Sebastianu Uppsala universitet,Molekylär systembiologi4 aut0 (Swepub:uu)sebde386 |
700 | 1 | a Fehr, Anthony R.u Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.4 aut |
700 | 1 | a Feijs, Karla L. H.u Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.4 aut |
700 | 1 | a Filippov, Dmitri V.u Leiden Univ, Leiden Inst Chem, Leiden, Netherlands.4 aut |
700 | 1 | a Gagné, Jean-Philippeu Laval Univ, Dept Mol Biol Med Biochem & Pathol, Fac Med, Quebec City, PQ, Canada.4 aut |
700 | 1 | a Grimaldi, Giovannau CNR, Naples, Italy.4 aut |
700 | 1 | a Guettler, Sebastianu Inst Canc Res ICR, Div Struct Biol, London, England.;Inst Canc Res ICR, Div Canc Biol, London, England.4 aut |
700 | 1 | a Hoch, Nicolas C.u Univ Sao Paulo, Dept Biochem, Sao Paulo, Brazil.4 aut |
700 | 1 | a Hottiger, Michael O.u Univ Zurich, Dept Mol Mech Dis, Zurich, Switzerland.4 aut |
700 | 1 | a Korn, Patriciau Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.4 aut |
700 | 1 | a Kraus, W. Leeu Univ Texas Southwestern Med Ctr, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX USA.4 aut |
700 | 1 | a Ladurner, Andreasu Ludwig Maximilians Univ Munchen, Dept Physiol Chem, Planegg Martinsried, Germany.4 aut |
700 | 1 | a Lehtiö, Lariu Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.;Bioctr Oulu, Oulu, Finland.4 aut |
700 | 1 | a Leung, Anthony K. L.u Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.4 aut |
700 | 1 | a Lord, Christopher J.u Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, CRUK Gene Funct Lab, London, England.4 aut |
700 | 1 | a Mangerich, Aswinu Univ Konstanz, Dept Biol, Constance, Germany.4 aut |
700 | 1 | a Matic, Ivanu Max Planck Inst Biol Ageing, Cologne, Germany.;Univ Cologne, Cologne Excellence Cluster Stress Responses Agein, Cologne, Germany.4 aut |
700 | 1 | a Matthews, Jasonu Univ Oslo, Inst Basic Med Sci, Oslo, Norway.4 aut |
700 | 1 | a Moldovan, George-Lucianu Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA USA.4 aut |
700 | 1 | a Moss, Joelu NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.4 aut |
700 | 1 | a Natoli, Gioacchinou European Inst Oncol IEO, Dept Expt Oncol, Milan, Italy.4 aut |
700 | 1 | a Nielsen, Michael L.u Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Prote Program,Ctr Prot Res, Copenhagen, Denmark.4 aut |
700 | 1 | a Niepel, Mariou Ribon Therapeut, Cambridge, MA USA.4 aut |
700 | 1 | a Nolte, Friedrichu Univ Klinikum Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.4 aut |
700 | 1 | a Pascal, Johnu Univ Montreal, Biochem & Mol Med, Montreal, PQ, Canada.4 aut |
700 | 1 | a Paschal, Bryce M.u Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA.4 aut |
700 | 1 | a Pawlowski, Krzysztofu Univ Texas Southwestern Med Ctr, Dept Mol Biol, Dallas, TX USA.4 aut |
700 | 1 | a Poirier, Guy G.u Laval Univ, Dept Mol Biol Med Biochem & Pathol, Fac Med, Quebec City, PQ, Canada.4 aut |
700 | 1 | a Smith, Susanu Univ Zurich, Dept Mol Mech Dis, Zurich, Switzerland.;NYU, Kimmel Ctr Biol & Med, Dept Pathol, Skirball Inst,Sch Med, New York, NY 10003 USA.4 aut |
700 | 1 | a Timinszky, Gyulau Eotvos Lorand Res Network ELKH, Lendulet Lab DNA Damage & Nucl Dynam, Inst Genet, Biol Res Ctr, Szeged, Hungary.4 aut |
700 | 1 | a Wang, Zhao-Qiu Leibniz Inst Aging, Fritz Lipmann Inst FLI, Jena, Germany.;Friedrich Schiller Univ Jena, Fac Biol Sci, Jena, Germany.4 aut |
700 | 1 | a Yelamos, Joseu Hosp del Mar Med Res Inst IMIM, Canc Res Program, Barcelona, Spain.4 aut |
700 | 1 | a Yu, Xiaochunu Westlake Univ, Sch Life Sci, Hangzhou, Peoples R China.4 aut |
700 | 1 | a Zaja, Rokou Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.4 aut |
700 | 1 | a Ziegler, Mathiasu Univ Bergen, Dept Biomed, Bergen, Norway.4 aut |
710 | 2 | a Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.b Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.4 org |
773 | 0 | t The FEBS Journald : John Wiley & Sonsg 289:23, s. 7399-7410q 289:23<7399-7410x 1742-464Xx 1742-4658 |
856 | 4 | u https://doi.org/10.1111/febs.16142y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1740444/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.16142 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-497477 |
856 | 4 8 | u https://doi.org/10.1111/febs.16142 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.